Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 83.01
+0.02 (0.02%)
Feb 28, 2025, 2:44 PM CST
Xiamen Amoytop Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 33,764 | 29,847 | 21,296 | 15,837 | 11,911 | 13,872 | Upgrade
|
| Market Cap Growth | 40.15% | 40.15% | 34.47% | 32.96% | -14.13% | - | Upgrade
|
| Enterprise Value | 33,190 | 29,272 | 20,670 | 15,360 | 11,446 | 13,419 | Upgrade
|
| Last Close Price | 83.00 | 73.37 | 51.97 | 38.45 | 28.81 | 33.50 | Upgrade
|
| PE Ratio | 40.89 | 36.06 | 38.34 | 55.18 | 65.73 | 119.00 | Upgrade
|
| Forward PE | 30.84 | 28.12 | 28.12 | 28.12 | 28.12 | 64.34 | Upgrade
|
| PS Ratio | 12.01 | 10.59 | 10.14 | 10.37 | 10.52 | 17.47 | Upgrade
|
| PB Ratio | 14.91 | 13.18 | 11.35 | 11.25 | 10.26 | 13.87 | Upgrade
|
| P/TBV Ratio | 14.31 | 14.31 | 12.64 | 12.32 | 11.74 | 16.75 | Upgrade
|
| P/FCF Ratio | - | - | 95.22 | 109.98 | 271.60 | - | Upgrade
|
| P/OCF Ratio | - | - | 41.59 | 43.61 | 50.73 | 149.79 | Upgrade
|
| EV/Sales Ratio | 11.78 | 10.39 | 9.84 | 10.06 | 10.11 | 16.90 | Upgrade
|
| EV/EBITDA Ratio | 32.44 | 28.62 | 29.03 | 38.09 | 43.97 | 81.31 | Upgrade
|
| EV/EBIT Ratio | 34.19 | 30.15 | 31.32 | 42.66 | 51.64 | 105.77 | Upgrade
|
| EV/FCF Ratio | - | - | 92.42 | 106.67 | 260.99 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.10 | 0.11 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.04 | 0.07 | 0.57 | - | Upgrade
|
| Asset Turnover | - | - | 1.02 | 0.96 | 0.87 | 0.80 | Upgrade
|
| Inventory Turnover | - | - | 0.90 | 1.39 | 1.18 | 1.01 | Upgrade
|
| Quick Ratio | - | - | 2.80 | 3.04 | 4.00 | 5.76 | Upgrade
|
| Current Ratio | - | - | 3.32 | 3.57 | 4.71 | 6.72 | Upgrade
|
| Return on Equity (ROE) | 39.97% | 39.97% | 33.83% | 22.35% | 16.76% | 14.91% | Upgrade
|
| Return on Assets (ROA) | - | - | 19.99% | 14.09% | 10.59% | 8.00% | Upgrade
|
| Return on Capital (ROIC) | 29.18% | 29.18% | 24.98% | 17.29% | 12.56% | 9.65% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 33.80% | 23.97% | 17.77% | 11.77% | Upgrade
|
| Earnings Yield | 2.45% | 2.77% | 2.61% | 1.81% | 1.52% | 0.84% | Upgrade
|
| FCF Yield | - | 1.05% | 0.91% | 0.37% | -0.19% | Upgrade
| |
| Dividend Yield | 0.49% | - | 0.79% | 0.55% | 0.35% | 0.15% | Upgrade
|
| Payout Ratio | 0.00% | - | 15.60% | 14.17% | 11.41% | 10.92% | Upgrade
|
| Buyback Yield / Dilution | -0.55% | -0.55% | -0.29% | -0.39% | -0.18% | -12.54% | Upgrade
|
| Total Shareholder Return | -0.06% | -0.55% | 0.50% | 0.16% | 0.17% | -12.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.